Impact of Dolutegravir-, Lopinavir/Ritonavir-, and Efavirenz-Based Antiretrovirals on Piperaquine Pharmacokinetics in Ugandan Children Living with HIV. [PDF]
Kajubi R +26 more
europepmc +1 more source
Presumed Relapse of Plasmodium vivax Malaria Presenting With Thrombocytopenia in a Non-endemic Area: A Case Report. [PDF]
Dewi KFP, Mulyani DP.
europepmc +1 more source
The Therapeutic Potential of Dihydroartemisinin in Cancer Treatment. [PDF]
Hu Z +7 more
europepmc +1 more source
Bilateral ascending dry gangrene following documented smear-positive malaria in a patient with multivalvular rheumatic heart disease and normal CT angiography findings: a case report. [PDF]
Deresse T +4 more
europepmc +1 more source
Genotype Complexity Modulates Antimalarial Susceptibility in vitro. [PDF]
Egwu CO +7 more
europepmc +1 more source
Anticancer power of Artemisia annua: A preclinical systematic review. [PDF]
Abdulsamad M, Musa EB, Miftah E.
europepmc +1 more source
Slowing the spread of treatment failure to artemisinin-based combination therapies in Uganda. [PDF]
Nguyen TD +12 more
europepmc +1 more source
Impact of intermittent preventive treatment for malaria in pregnancy with sulfadoxine-pyrimethamine, dihydroartemisinin-piperaquine, and their combination on infant outcomes: A randomized controlled trial. [PDF]
Nankabirwa JI +13 more
europepmc +1 more source
Reappraising the cardiosafety of dihydroartemisinin-piperaquine
The arsenal of efficacious drugs for the treatment of malaria remains small and is clearly insufficient to tackle the global burden of malaria, with more than 216 million clinical episodes and nearly half a million deaths annually.1 Among the new ...
Bassat Orellana, Quique +1 more
core
Why are iron chelators not as effective as artemisinin in killing malaria parasites? [PDF]
Sun J +6 more
europepmc +1 more source

